QELBREE
Generic: viloxazine hydrochloride
- Manufacturer
- Supernus
- NDC
- 17772-131
- RxCUI
- 2536548
- Route
- ORAL
- ICD-10 indication
- F90.9
Affordability Check
How much will you actually pay for QELBREE?
In 30 seconds, see every legitimate way to afford QELBREE — Medicare copay, manufacturer copay card, Patient Assistance Program, grants, or cash.
About QELBREE
What is this medication? Qelbree is a prescription medication used for the treatment of attention-deficit hyperactivity disorder, commonly known as ADHD. It is approved for use in both children aged six and older as well as in adults. Unlike many other common treatments for this condition, Qelbree is a non-stimulant medication. It belongs to a class of drugs called selective norepinephrine reuptake inhibitors, which work by increasing the levels of certain natural substances in the brain that help manage focus and impulse control.
This medication is typically taken once daily in the form of an extended-release capsule. Because it is not a controlled substance, it does not carry the same potential for abuse or dependence as many stimulant-based ADHD treatments. Healthcare providers often prescribe it to help patients reduce symptoms such as hyperactivity, distractibility, and impulsiveness. It is important for patients and caregivers to monitor for any changes in mood or behavior while using this drug, as is standard with many medications that affect the central nervous system.
Copay & patient assistance
- Patient Copay Amount: Not Publicly Available
- Maximum Annual Benefit Limit: Not Publicly Available
- Core Eligibility Restrictions: Offer is available to most commercially insured and cash-paying patients; not valid for patients enrolled in Medicaid, Medicare, or any other federal or state healthcare program (including medical assistance programs); valid only for Qelbree prescriptions in the United States and Puerto Rico; not valid where prohibited by law; cannot be combined with any other offer.
- RxBIN, PCN, and Group numbers: Not Publicly Available
External links go directly to the manufacturer's portal. RxCopays does not receive compensation for referrals.
Compare pricing elsewhere
RxCopays doesn't sell drugs or take referral fees. Here are the transparent-pricing directories we recommend checking alongside your insurance formulary.
Cost Plus Drug Company
Mark Cuban's transparent-pricing pharmacy — manufacturer cost + 15% markup + $5 dispensing fee. No insurance needed. Search alphabetically for viloxazine hydrochloride.
Browse Cost Plus medications →
GoodRx
Compare local pharmacy prices with GoodRx coupons. Use the price with your insurance or without — whichever is cheaper.
Lookup QELBREE →
NeedyMeds
Independent nonprofit directory of patient assistance programs, copay cards, and charity co-pay foundations.
Search for viloxazine hydrochloride →
RxAssist
PAP directory maintained by Volunteers in Health Care at Brown University. Free, no ads.
Search PAPs →
We deep-link because transparency helps patients. None of these partners pay RxCopays.
Conditions we've indexed resources for
Click a condition to see copay cards, grants, and PA rules specific to it. For the full list of FDA-approved indications, see Prescribing information above.
Medicare Part D coverage
How QELBREE appears across Medicare Part D plan formularies nationally. Source: CMS monthly Prescription Drug Plan file (2026-08-31).
Covered by plans
0%
16 of 5,499 plans
Most common tier
Tier 4
On 67% of covering formularies
Prior authorization required
33%
of covering formularies
| Tier | Formularies on this tier | Share |
|---|---|---|
| Tier 2 (generic) | 1 | 33% |
| Tier 4 (non-preferred brand) | 2 | 67% |
Step therapy: 67% of formularies
Quantity limits: 100% of formularies
Coverage breadth: 3 of 65 formularies
How to read this:plans on the same formulary share tier + PA rules. Your specific plan's copay depends on (a) the tier above, (b) your plan's cost-share for that tier, (c) whether you're in the initial coverage phase or past the 2026 $2,000 out-of-pocket cap. For your exact plan, check its Summary of Benefits or log in to your Medicare.gov account. Copay cards don't apply to Medicare (federal law).
Prior authorization & coverage
| Payer | PA | Step therapy | Copay tier |
|---|---|---|---|
— Medicare Part D | — | — | — |
Related drugs
Dextroamphetamine Saccharate and Amphetamine Aspartate and Dextroamphetamine Sulfate and Amphetamine Sulfate
Treats same condition · Dextroamphetamine Saccharate and Amphetamine Aspartate and Dextroamphetamine Sulfate and Amphetamine Sulfate
Adderall
Treats same condition · Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, and Amphetamine Sulfate
Strattera
Treats same condition · Atomoxetine hydrochloride
DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE
Treats same condition · Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate
METHYLPHENIDATE HYDROCHLORIDE
Treats same condition · methylphenidate hydrochloride
QuilliChew ER
Treats same condition · methylphenidate hydrochloride
PROCENTRA
Treats same condition · dextroamphetamine sulfate
Cotempla XR-ODT
Treats same condition · Methylphenidate
Guanfacine ER
Treats same condition · Guanfacine ER
Atomoxetine Hydrochloride
Treats same condition · atomoxetine hydrochloride
How this page is sourced
- Drug identity verified against openFDA NDC Directory.
- Label text (when shown) originates from NLM DailyMed.
- Copay and assistance URLs verified periodically; if you hit a broken link, tell us.